Nova Leap Health Yönetim
Yönetim kriter kontrolleri 2/4
We currently do not have sufficient information about the CEO.
Anahtar bilgiler
Chris Dobbin
İcra Kurulu Başkanı
US$271.7k
Toplam tazminat
| CEO maaş yüzdesi | 22.2% |
| CEO görev süresi | 9yrs |
| CEO sahipliği | 10.1% |
| Yönetim ortalama görev süresi | Veri yok |
| Yönetim Kurulu ortalama görev süresi | 8.1yrs |
Son yönetim güncellemeleri
Recent updates
Nova Leap Health Corp.'s (CVE:NLH) 35% Share Price Surge Not Quite Adding Up
Oct 31
Risks Still Elevated At These Prices As Nova Leap Health Corp. (CVE:NLH) Shares Dive 27%
Sep 12Nova Leap Health Corp.'s (CVE:NLH) 33% Price Boost Is Out Of Tune With Revenues
Jun 08Should Shareholders Reconsider Nova Leap Health Corp.'s (CVE:NLH) CEO Compensation Package?
May 31Nova Leap Health Corp. (CVE:NLH) Looks Just Right With A 28% Price Jump
Mar 23Market Participants Recognise Nova Leap Health Corp.'s (CVE:NLH) Revenues
Jan 06Nova Leap Health Corp. (CVE:NLH) Investors Are Less Pessimistic Than Expected
Jul 29Does Nova Leap Health (CVE:NLH) Have A Healthy Balance Sheet?
Feb 22Calculating The Intrinsic Value Of Nova Leap Health Corp. (CVE:NLH)
Aug 17Nova Leap Health (CVE:NLH) Is Carrying A Fair Bit Of Debt
May 14Estimating The Intrinsic Value Of Nova Leap Health Corp. (CVE:NLH)
Oct 22Nova Leap Health (CVE:NLH) Strong Profits May Be Masking Some Underlying Issues
Mar 18CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$126k |
| Mar 31 2024 | n/a | n/a | -US$285k |
| Dec 31 2023 | US$272k | US$60k | -US$1m |
| Sep 30 2023 | n/a | n/a | -US$1m |
| Jun 30 2023 | n/a | n/a | -US$902k |
| Mar 31 2023 | n/a | n/a | -US$743k |
| Dec 31 2022 | US$259k | US$59k | -US$836k |
| Sep 30 2022 | n/a | n/a | -US$592k |
| Jun 30 2022 | n/a | n/a | US$119k |
| Mar 31 2022 | n/a | n/a | US$489k |
| Dec 31 2021 | US$292k | US$63k | US$2m |
| Sep 30 2021 | n/a | n/a | US$4m |
| Jun 30 2021 | n/a | n/a | US$3m |
| Mar 31 2021 | n/a | n/a | US$2m |
| Dec 31 2020 | US$248k | US$63k | US$1m |
| Sep 30 2020 | n/a | n/a | -US$278k |
| Jun 30 2020 | n/a | n/a | -US$789k |
| Mar 31 2020 | n/a | n/a | -US$313k |
| Dec 31 2019 | US$235k | US$193k | -US$1m |
| Sep 30 2019 | n/a | n/a | -US$730k |
| Jun 30 2019 | n/a | n/a | -US$1m |
| Mar 31 2019 | n/a | n/a | -US$922k |
| Dec 31 2018 | US$249k | US$176k | -US$961k |
| Sep 30 2018 | n/a | n/a | -US$1m |
| Jun 30 2018 | n/a | n/a | -US$1m |
| Mar 31 2018 | n/a | n/a | -US$1m |
| Dec 31 2017 | US$95k | US$95k | -US$852k |
Tazminat ve Piyasa: Chris's total compensation ($USD271.70K) is above average for companies of similar size in the Canadian market ($USD171.96K).
Tazminat ve Kazançlar: Chris's compensation has been consistent with company performance over the past year.
CEO
Chris Dobbin (49 yo)
9yrs
Görev süresi
US$271,704
Tazminat
Mr. Christopher Donald Dobbin, also known as Chris, C.P.A., C.A., ICD D., serves as the Chief Executive Officer and President of Nova Leap Health Corp. and served as its Chief Financial Officer until Octob...
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO, President & Director | 9yrs | US$271.70k | 10.08% CA$ 2.7m | |
| Independent Director | 9yrs | US$27.17k | 2.58% CA$ 689.4k | |
| Independent Chairman of the Board | 9yrs | US$45.28k | 3.45% CA$ 922.9k | |
| Independent Director | 3.7yrs | US$22.64k | 0.079% CA$ 21.1k | |
| Independent Director | 3.6yrs | US$22.64k | Veri yok | |
| Independent Director | 7.2yrs | US$27.17k | 4.31% CA$ 1.2m |
8.1yrs
Ortalama Görev Süresi
50yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: NLH's board of directors are considered experienced (8.1 years average tenure).